REVISITING THE CONTENT OF NON-SPECIFIC INFLAMMATORY PROCESS MARKERS AND 25-HYDROXYVITAMIN D IN THE BLOOD OF PREGNANT WOMEN OF HIGH INFECTIOUS RISK
Clinical medicine

REVISITING THE CONTENT OF NON-SPECIFIC INFLAMMATORY PROCESS MARKERS AND 25-HYDROXYVITAMIN D IN THE BLOOD OF PREGNANT WOMEN OF HIGH INFECTIOUS RISK

Published 2022-11-30

Authors:

G.S. Manasova
N.V. Didenkul
N.V. Kuzmin
I.V. Shpak
O.V. Zhovtenko

Abstract:
Intrauterine infection continues to have a negative impact on perinatal indicators. The aim of the study was to compare the concentration of some markers of the inflammatory process and vitamin D in the blood of pregnant women with placental dysfunction against the background of high infection risk (56 women – a group I), as well as in healthy pregnant women (40 women – group II). Blood levels of procalcitonin, lactate, C-reactive protein and vitamin D were determined by ELISA. More than 60 % of pregnant women from the I-st group were carriers of CMV, HSV, and toxoplasmosis. The violation of the vaginal ecosystem was determined in them 5 times more often than in group II. The level of vitamin D in the I-st group was lower than in the comparison group (31.73±8.6 ng/ml and 43.38±11.20 ng/ml; U=502.5, P=0.00001), and the content of C-reactive protein (15 times), procalcitonin (3 times) and lactate (2.2 times) was greater than in the control group. Low blood levels of calcidiol are associated with high levels of inflammatory markers. It is possible that the correction of vitamin D status in the pre-gravid stage and from the early stages of pregnancy in women at high infectious risk can contribute to the improvement of perinatal outcomes.
Keywords:
pregnancy intrauterine infection vitamin D procalcitonin lactate C-reactive protein
References:
  1. Aylamazyan EK, Shipitsyna YeV, Savicheva AM. Mikrobiota zhenshchiny i iskhody beremennosti. Zhurnal akusherstva i zhenskikh bolezney.2016;65(4):6–14. DOI: 10.17816/JOWD6546-14 [in Russian]
  2. Aguin TJ, Sobel JD. Vulvovaginal candidiasis in pregnancy. Curr. Infect. Dis. Rep.2015;17:462. doi: 10.1007/s11908-015-0462-0
  3. Berezhna VA, Mamontova TV, Gromova AV. CD68+ M1 Macrophages is associated with placental insufficiency under fetal growth restriction. Wiadomości Lekarskie. 2021;LXXIV(2):213–219. DOI:10.36740/WLek202102107
  4. Donders GGG, Bellen G, Grinceviciene S, Ruban K, Vieira-Baptista P. Aerobic vaginitis: no longer a stranger. Res Microbiol. 2017 Nov-Dec;168(9–10):845–858. doi: 10.1016/j.resmic.2017.04.004.
  5. Donders GGG, Ruban K, Bellen G, Petricevic L. Mycoplasma/Ureaplasma infection in pregnancy: to screen or not to screen. J Perinat Med. 2017 Jul 26;45(5):505–515. doi: 10.1515/jpm-2016-0111.
  6. Gil Á, Plaza-Diaz J, Mesa MD. Vitamin D: Classic and Novel Actions. Ann Nutr Metab. 2018;72(2):87–95. doi: 10.1159/000486536.
  7. Knabl J, Vattai A, Jueckstock J, Hutter S, Kainer F. Role of Placental VDR Expression and Function in Common Late Pregnancy Disorders. Int J Mol Sci. 2017 Nov 6;18(11):2340. doi: 10.3390/ijms18112340. PMID: 29113124; PMCID: PMC5713309.
  8. Ostrander B, Bale JF. Congenital and perinatal infections. Handb Clin Neurol. 2019;162:133–153. doi: 10.1016/B978-0-444-64029-1.00006-0.
  9. Page JM, Bardsley T, Thorsten V, Allshouse AA, Varner MW, Debbink MP et al. Stillbirth Associated With Infection in a Diverse U.S. Cohort. Obstet Gynecol. 2019 Dec;134(6):1187–1196. doi: 10.1097/AOG.0000000000003515.
  10. Palasanthiran P, Starr M, Jones C, Giles M. Management of Perinatal Infections. Australasian Society for Infectious Diseases [Internet]. 2014[cited 2019 Dec 19]:92. Available from: https://www. asid.net.au/documents/item/368
  11. Raymond SL, Rincon JC, Wynn JL, Moldawer LL, Larson SD. Impact of Early-Life Exposures to Infections, Antibiotics, and Vaccines on Perinatal and Long-term Health and Disease. Front. Immunol. 2017;8:729. doi: 10.3389/fimmu.2017.00729
  12. Rittenschober-Böhm J, Waldhoer T, Schulz SM, Pimpel B, Goeral K, Kasper DC et al. Vaginal Ureaplasma parvum serovars and spontaneous preterm birth. Am J Obstet Gynecol 2019;220: 594.e1–9. DOI: https://doi.org/10.1016/j.ajog.2019.01.237.
  13. Siniakova AA. Current views on vaginal microbiota and its impact on pregnancy outcomes. Journal of Obstetrics and Women’s Diseases. 2017;66(6):89–100. doi: 10.17816/JOWD66689-100)
  14. Waikhom SD, Afeke I, Kwawu GS, Mbroh HK, Osei GY, Louis B et al. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. BMC Pregnancy Childbirth. 2020 May 6;20(1):266. doi: 10.1186/s12884-020-02963-3.
Publication:
«World of Medicine and Biology» Vol. 18 No. 82 (2022) , с. 118-123
УДК 618.3-06:618.1-002-022.7]-074:616.15